Stanford University
Showing 11,501-11,600 of 12,891 Results
-
Zhainib A. Amir
Ph.D. Student in Biology, admitted Autumn 2020
BioI received my B.S. in Microbiology, and M.S. in Cell and Molecular Biology from San Francisco State University. Currently, I am a Biology Ph.D. student with an emphasis in Cell, Molecular and Organismal Biology at Stanford University. I am interested in a range of topics, from cell biology to cancer immunology, however, my research interests lie primarily in understanding the cellular mechanisms at play in genetic and autoimmune diseases.
-
Suji Uhm, MD, MPH
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Suji Uhm is a board-certified obstetrician-gynecologist at Stanford Health Care. She also serves as a clinical associate professor in the Department of Obstetrics & Gynecology, Division of Gynecology & Gynecologic Specialties at Stanford University School of Medicine.
Dr. Uhm offers a wide range of gynecologic services, including gynecologic care, routine and complex contraceptive and abortion services, and wellness exams. She strives to provide safe, patient-centered care and often cares for patients who have medical conditions that complicate contraceptive use or report prior negative experiences.
Dr. Uhm’s research focuses on assessing the safety and effectiveness of contraceptive methods. She has been an investigator in multiple industry-sponsored and National Institutes of Health (NIH)-funded studies, including the evaluation of extending the use of a subdermal implant, nonhormonal IUD, vaginal ring, and contraceptive patch.
Dr. Uhm has been published in several peer-reviewed journals, including Contraception, Nature, and The American Journal of Surgery. She has also presented to colleagues at regional, national, and international meetings, including the Society of Family Planning (SFP) annual meeting.
Dr. Uhm is a fellow of the American College of Obstetricians and Gynecologists (ACOG) and SFP. She is also a member of the National Abortion Federation and Physicians for Reproductive Health. -
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Affiliate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child DevelopmentBioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Ummey Hani, MBBS, MD
Postdoctoral Scholar, Neurosurgery
BioHani is a Postdoctoral Research Fellow at Stanford University in the Neurosurgical Artificial Intelligence and Machine Learning Laboratory. She earned her medical degree from Sindh Medical College, Pakistan, and completed her internship at the Aga Khan University, where she was recognized as Class Valedictorian and among the top five interns of 2022. She then pursued a two-year postdoctoral fellowship at Carolina Neurosurgery and Spine Associates in Charlotte, North Carolina, affiliated with Wake Forest University School of Medicine, focusing on spine surgery outcomes and biomechanics. Before joining Stanford, she served as Junior Research Faculty for neuro-oncology research at the Aga Khan University in Karachi, Pakistan.
Hani’s research spans neuro-oncology, spine surgery, biomechanics, and the application of AI/ML in neurosurgical innovation. With a deep commitment to academic neurosurgery, she is currently working towards securing a neurosurgical residency. -
Ndidi Unaka
Clinical Professor, Pediatrics
BioDr. Unaka is the inaugural Chief Health Equity Officer (CHEO) for Stanford Medicine Children’s Health (SMCH) and a Clinical Professor in the Department of Pediatrics at Stanford University School of Medicine. Prior to her transition to SMCH in July 2024, Dr. Unaka was a faculty member in the Division of Hospital Medicine at Cincinnati Children's Hospital. In addition to her clinical role as a pediatric hospitalist, Dr. Unaka served as the Associate Program Director of the Pediatric Residency Program from 2011 – January 2022. She served as the medical director of a 48- bed inpatient unit primarily for patients admitted to the Hospital Medicine service. In this role, Dr. Unaka was involved in several equity-oriented quality improvement initiatives which included work to identify, and address hunger among caregivers of hospitalized children insured by Medicaid.
Dr. Unaka worked on institution-level community health initiatives at Cincinnati Children’s. She served as the Medical Director of Quality Improvement and Data Analytics for Cincinnati Children’s Medicaid- focused, accountable care organization (HealthVine). In this role, she developed and led initiatives designed to improve the quality and efficiency of health care delivery to HealthVine’s patient population and helped lead the change management associated with the movement toward a population-health care model that improves quality, narrows equity gaps, streamlines care, and reduces costs. She helped define appropriate health care delivery, equity, and population health measures and quality benchmarks. Additionally, Dr. Unaka was a faculty lead within Cincinnati Children's Fisher Child Health Equity Center, and she specifically focused on working with operations leaders to ensure equity was embedded within all strategic plans, goals, and metrics across all sites of care. Dr. Unaka partnered with several colleagues to lead system-wide quality improvement initiatives including work accelerated via learning networks. She was the co-lead of Cincinnati Children's Health Equity Network (HEN), an initiative borne out of the pursuit of excellent and equitable health outcomes for youth in Greater Cincinnati. The HEN supports clinical teams seeking to eliminate disparities in child health outcomes by race, ethnicity, and/or socioeconomic status via targeted interventions and best practices by addressing both medical and social factors known to confer poor health outcomes. -
Rachel Allison Ungar
Postdoctoral Scholar, Biomedical Ethics
BioRachel Ungar, PhD, is a Postdoctoral Fellow in the Stanford Training Program in ELSI Research (T32) at the Stanford Center for Biomedical Ethics. Her graduate research was in computational genomics focused on multiomics approaches in Stephen Montgomery’s lab. She was an active member of the Undiagnosed Diseases Network, and GREGoR rare disease consortia focused on transcriptomic methods and data standards. She also examined the impact of rare variants and sex on the X-chromosome. During her PhD, she co-created and taught a course expanding ethics education to bioscientists (GENE 220: Genetics, Ethics, and Society) and evaluated its impact. During her postdoc, Rachel aims to use her background to integrate genomics and ethics, beginning with ethical considerations for rare and undiagnosed disorders. Rachel received her PhD in Genetics at Stanford. She earned her Bachelor of Science in Biology at the University of Arkansas with minors in mathematics and computer science.
-
Crystal Unzueta, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Unzueta is a board-certified family medicine physician. She specializes in providing primary care services to people of all ages. Her services include annual check-ups, monitoring chronic conditions, and performing minor in-office procedures.
She is also a clinical assistant professor in the Stanford School of Medicine Department of Family Medicine.
Dr. Unzueta’s practice focuses on providing compassionate and comprehensive care. She specializes in providing bilingual and bicultural care for patients in underserved populations. She has traveled to Belize on a medical mission to provide free, basic primary care to vulnerable communities. Her mentoring work includes building a network of Latino medical students to help support each other throughout medical school. She has also worked on numerous volunteer projects, such as researching the benefits of a community yoga program for minorities in underserved areas. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
PJ Utz
Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.
-
Chibuike Uwakwe
MD Student, expected graduation Spring 2028
Ph.D. Student in Bioengineering, admitted Autumn 2025
MSTP Student
Tutor, SoM Office of Student ServicesCurrent Research and Scholarly InterestsWearable bioelectronics for continuous health monitoring and therapeutics
-
Sivakamasundari V
Instructor, Institute for Stem Cell Biology and Regenerative Medicine
BioMy research interests are focused on understanding the molecular basis of early development and stem cells, as it is often aberrations in stem cells or signaling mechanisms between tissues that lead to diseased states, including tumor development and cancer progression. Knowledge of stem cells and development is also critical to develop appropriate cell-based therapies for various diseases or injuries. My prior and current works take advantage of both traditional techniques (gene targeting, lineage tracing) and state-of-the-art technologies (Single cell RNA sequencing, Chromatin Immunoprecipitation (ChIP-seq), Imaging Mass Cytometry) to elucidate fundamental molecular mechanisms underlying signaling in tissue biology.
-
Randall Vagelos, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsI. Congestive Heart Failure New Medical Therapies Prognostic Evaluation Selection for Cardiac Transplantation II. Screening for Myocardial Necrosis New ECG Monitoring Devices New Serum Markers III. Screening for CAD Patients Who Have Received Radiation Rx Diabetics Being Considered for Renal Transplantation
IV. Advanced coronary and valvular disease, evaluationg candidacy for high risk interventions. -
Homa Vahidi
MD Student with Scholarly Concentration in Informatics & Data-Driven Medicine / Neuroscience, Behavior, and Cognition, expected graduation Spring 2029
BioI was born in Iran and moved to Canada at the age of 15 where I completed my undergraduate and graduate studies in Neuroscience. I primarily have work experience in academic and research settings and have become increasingly passionate about doing research that helps uncover the neural underpinnings of cognition, language, and social behaviours.
-
Sharif Vakili, MD, MBA, MS
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSharif Vakili, MD, MBA, MS, (pronouns: he/him), is an internal medicine physician, clinician executive and educator. He practices at Stanford Los Altos Primary Care.
Dr. Vakili has a background in chronic disease management and health systems delivery, believing strongly in a teamwork approach to patient care that empowers patients to navigate the health system as part of their clinical care.
He is active in the research and business communities. His research has been in peer-reviewed journals including NEJM Catalyst, JAMA Network Open and the Annals of Emergency Medicine. He also teaches annually at the Stanford Graduate School of Business.
Dr. Vakili is credited with establishing and coining Remote Patient Intervention (RPI), a model of clinician-supervised AI care delivery first performed at Stanford during a clinical study published in JAMA Network Open. His work has defined the emerging field of Clinical AI, in which artificial intelligence delivers care that would otherwise be performed by a licensed practitioner. -
Hannah Valantine
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure.
-
Tulio Valdez, MD, MSc
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioDr. Tulio A Valdez is a surgeon scientist with a subspecialty interest in Pediatric Otolaryngology. He attended medical school at Universidad Javeriana in Bogota Colombia before undertaking his residency in Otolaryngology, Head and Neck Surgery in Boston. He completed his Pediatric Otolaryngology Fellowship at Texas Children’s Hospital (2007), Houston and obtained his Master’s in Clinical and Translational Research at the University of Connecticut.
Clinically, Dr. Valdez has an interest in pediatric sleep apnea. He has a special interest in the management of sinus disease in cystic fibrosis. Dr. Valdez has co-authored one textbook and numerous book chapters and scientific manuscripts. Dr. Valdez continues his clinical research in these areas, particularly with a focus on aerodigestive disorders.
Scientifically, Dr. Valdez has developed various imaging methods to diagnose otitis media and cholesteatoma a middle ear condition that can lead to hearing loss. He was part of the Laser Biomedical Research Center at the Massachusetts Institute of Technology. His research includes novel imaging modalities to better diagnose ear infections one of the most common pediatric problems. His research has now expanded to include better intraoperative imaging modalities in pediatric patients to improve surgical outcomes without the need for radiation exposure.
Dr. Valdez believes in multi-disciplinary collaborations to tackle medical problems and has co-invented various medical devices and surgical simulation models. -
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Axel Valle, PsyD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Axel Valle is a licensed clinical psychologist providing individual psychotherapy in English and Spanish. He specializes in cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) and anxiety disorders, with additional expertise in working with high-performance athletes.
Dr. Valle brings a distinctive international clinical background to his practice. He completed his postdoctoral fellowship at Stanford University School of Medicine’s Department of Psychiatry and Behavioral Sciences and earned his doctorate in clinical psychology from The Wright Institute in Berkeley. He also holds a Master’s degree in crisis and trauma from Tel Aviv University and is a licensed clinical psychologist in Mexico City, his place of origin. -
Eline van Beest
Affiliate, School of Medicine - MDRP'S - Biodesign Program
BioEline founded the TUDelft spin-off and MedTech scale-up NightBalance in 2009 with a new therapy for sleep apnea. NightBalance was acquired by Philips in 2018. Currently, she Operating Partner at Thuja Capital and CEO of Hybridize Therapeutics, a spin-off from the LUMC that develops RNA-based therapies for kidney diseases. Besides that she is part of the Investment Committee of the Deep Tech Fund of EZ & InvestNL, the VGZ Voorop in Zorg Fonds and the Graduate Ventures Pre Seed Fund and is a member of the Supervisory Board of Yes!Delft (a leading tech incubator in Europe supporting 280 startups).
-
Laura van Dam
Postdoctoral Scholar, Immunology and Rheumatology
BioI am both trained as a biomedical researcher and medical doctor in internal medicine and strive to close the gap between the clinic and fundamental sciences with translational research. My focus is to study the mechanisms of autoimmune diseases and to translate research insights into therapeutics targeting autoimmunity. I have received my PhD in 2022 in Leiden for studying neutrophil extracellular traps and autoreactive B cells in renal autoimmune diseases. My postdoctoral research project in the Robinson lab focuses on investigating the underlying molecular mechanisms of the pathogenesis of ANCA-associated vasculitis. I particularly aim to identify potential microbial triggers and molecular mimicry in ANCA-associated vasculitis, by characterizing the nasal microbiome and sequencing T cells and B cells of ANCA-associated vasculitis patients.
-
Matt van de Rijn
Sabine Kohler, MD, Professor of Pathology, Emeritus
Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.
-
Stephanie Van de Ven
Member, Stanford Cancer Institute
BioAs Deputy Director of the Canary Center at Stanford for Cancer Early Detection I broadly oversee its operations and research programs. The Canary Center is focused on developing in vitro and in vivo tools for early cancer detection and its research spans the areas of biomarker discovery, development of molecular imaging agents, development of new diagnostic and imaging devices, and mathematical modeling. In my position I facilitate the clinical translation of cancer diagnostic tools and I enable innovative interdisciplinary research. My research expertise includes leading phase I-II clinical trials to evaluate a newly developed optical breast imaging system in combination with a novel imaging agent. I gained valuable experience in clinical translation of medical devices and in testing new imaging agents for the first time in patients. My training as a Radiology resident was instrumental in my decision to focus on cancer early detection research, because it clearly confronted me with the problem that most cancer patients are being diagnosed too late. I expanded my knowledge on biomarker research by developing proteomics assays during my postdoctoral fellowship at Stanford, in conjunction with my continued work in optical and photoacoustic molecular imaging. In my current role, I work with the faculty of the Canary Center and the Molecular Imaging Program at Stanford, and am committed to advancing cancer research by applying my medical training, clinical knowledge, and research expertise to managing collaborative programs and contribute to the success of the Center and its faculty.
-
Laurens van de Wiel
Postdoctoral Scholar, Cardiovascular Medicine
BioI am a post-doctoral researcher at Stanford University under supervision of Matthew Wheeler and Stephen Montgomery. My research focuses on understanding the entire spectrum of genetic variation effects on protein function and structure in order to decipher molecular mechanisms of disease.
My post-doctoral work centers on developing novel software methodologies which combine multi-omics data to interpret the functional impact of genetic variants in undiagnosed patients. I am part of the Undiagnosed Disease Network (UDN) at Stanford Center for Undiagnosed Diseases (CUD), Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) consortium at GREGoR Stanford Site (GSS), and the Molecular Transducers of Physical Activity Consortium (MoTrPAC) at the Bioinformatics Center (BIC).
Before joining Stanford. I was received my Ph.D. in 2021 at the Radboud University Medical Center under supervision of Christian Gilissen, Gert Vriend, and Joris Veltman. I received my MSc degree in 2014 at Radboud University under supervision of Tom Heskes, Evgeni Levin, and Armand Paauw. Before my Ph.D, I worked as a Data Scientist at FLXone, where I developed machine learning solutions within a large-scale, real-time infrastructure.
Research
I am interested in a variety of topics in Bioinformatics and Computer Science. In particular, I am interested in the application of Artificial Intelligence and Statistical Modelling to analyse human (Rare) Mendelian Disease Genetics, Evolutionary Comparative Genomics, Protein Domain Homology, and Molecular Structures. -
Pieter van der Starre
Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCardiovascular Pharmacology, Cardiovascular Physiology,
Neurophysiology and Monitoring,
Transesophageal Echocardiography -
Keith Van Haren, MD
Associate Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsOur research team is working to develop new treatments for children at risk of neurodegenerative diseases. We are primarily focused on multiple sclerosis and X-linked adrenoleukodystrophy, two conditions that involve inflammatory and metabolic disruption of the myelin that insulates brain cells. A key area of interest for us is how nutrient deficiencies during childhood may contribute to the disease processes and whether nutritional interventions could play a role in prevention.
-
Krisa Van Meurs
Rosemarie Hess Professor, Emerita
Current Research and Scholarly InterestsMy research interests include persistent pulmonary hypertension of the newborn, hypoxic respiratory failure, inhaled nitric oxide therapy, ECMO, congenital diaphragmatic hernia, neonatal clinical trials, and the use of aEEG and NIRS to detect brain injury.
-
Roxanna Van Norman
Sr. Marketing Manager, Cardiothoracic Surgery
Current Role at StanfordSr. Marketing Manager, Stanford University School of Medicine, Department of Cardiothoracic Surgery
-
Max Van Puyvelde
Graduate, Medicine, School of Medicine
BioMax Van Puyvelde is a PhD student and Visiting Student Researcher at the Division of Computational Medicine at Stanford University, jointly supervised by Prof. Olivier Gevaert (Stanford) and Prof. Wim Van Criekinge (Ghent University). His research centers on foundation models and deep learning for medical imaging, with a focus on 3D vision models, vision-language models, and multimodal fusion across imaging, clinical, and genomic data. Max holds a background in bioinformatics and machine learning, with prior experience across startups, consulting, and scientific advising in the AI space.
-
Capucine Van Rechem
Assistant Professor of Pathology (Pathology Research)
Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.
-
Peter Johannes van Roessel
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD, PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment and Psychodynamic Psychotherapy Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology and co-leads a new adult outpatient ketamine-assisted psychotherapy clinic.
As Director of Clinical Research for the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive awareness ('insight') in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control and the processing of incongruity and error. Dr. van Roessel additionally contributes as co-investigator to the Suppes Exploratory Therapeutics Laboratory and to the Williams PANLab, on clinical trials advancing psychedelic-assisted psychotherapies and biomarker-informed precision medicine in depression and posttraumatic stress disorder.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Henk van Voorst
Postdoctoral Scholar, Radiology
BioDr. van Voorst is a postdoctoral scholar in Radiology studying the interfaces of artificial intelligence and neuroradiological imaging in stroke. Originally educated as an MD, Dr. van Voorst gained additional degrees in Finance and Data Science. As a PhD student, Dr. van Voorst focused on cost-effectiveness modeling and developed machine learning and deep learning algorithms with applications in acute ischemic stroke imaging. In his current research, Dr. van Voorst develops artificial intelligence algorithms to automatically extract information from arteries and veins in radiological stroke imaging.
